477 results on '"Nick, Jerry A."'
Search Results
2. Nontuberculous Mycobacterial Infections in Cystic Fibrosis
3. Host and pathogen response to bacteriophage engineered against Mycobacterium abscessus lung infection
4. Modeling cystic fibrosis patient prognosis: Nomograms to predict lung transplantation and survival prior to highly effective modular therapy.
5. Nontuberculous mycobacterial infection and environmental molybdenum in persons with cystic fibrosis: a case–control study in Colorado
6. Population Genomics and Inference of Mycobacterium avium Complex Clusters in Cystic Fibrosis Care Centers, United States
7. Pharmacokinetics of oral antimycobacterials and dosing guidance for Mycobacterium avium complex treatment in cystic fibrosis
8. Safety and efficacy of the cystic fibrosis transmembrane conductance regulator potentiator icenticaftor (QBW251)
9. Clinical characteristics and outcomes associated with Inquilinus infection in cystic fibrosis
10. Urine lipoarabinomannan as a marker for low-risk of NTM infection in the CF airway
11. Genomic Epidemiology ofMycobacterium abscessusat an Adult Cystic Fibrosis Program Reveals Low Potential for Healthcare-Associated Transmission
12. Nonantibiotic Management of Nontuberculous Mycobacteria in Non–Cystic Fibrosis Bronchiectasis: Natural or Nonsense?
13. Ivacaftor in cystic fibrosis with residual function: Lung function results from an N-of-1 study
14. Long-Term Ivacaftor in People Aged 6 Years and Older with Cystic Fibrosis with Ivacaftor-Responsive Mutations
15. Antisense oligonucleotide eluforsen improves CFTR function in F508del cystic fibrosis
16. Nontuberculous Mycobacterial Infections in Cystic Fibrosis
17. Genomic epidemiology of Mycobacterium abscessus at an adult cystic fibrosis programme reveals low potential for healthcare-associated transmission.
18. CFTR modulator theratyping: Current status, gaps and future directions
19. Culturing Mycobacteria
20. Nontuberculous mycobacteria in cystic fibrosis
21. Prospective healthcare-associated links in transmission of nontuberculous mycobacteria among people with cystic fibrosis (pHALT NTM) study: Rationale and study design
22. MODELING CYSTIC FIBROSIS PATIENT PROGNOSIS: NOMOGRAMS TO PREDICT LUNG TRANSPLANTATION AND SURVIVAL PRIOR TO HIGHLY EFFECTIVE MODULATOR THERAPY
23. Prospective evaluation of nontuberculous mycobacteria disease in cystic fibrosis: The design of the PREDICT study
24. Safety and Effectiveness of Clofazimine for Primary and Refractory Nontuberculous Mycobacterial Infection
25. Standardized Treatment of Pulmonary Exacerbations (STOP) study: Observations at the initiation of intravenous antibiotics for cystic fibrosis pulmonary exacerbations
26. Standardized Treatment of Pulmonary Exacerbations (STOP) study: Physician treatment practices and outcomes for individuals with cystic fibrosis with pulmonary Exacerbations
27. Impact of azithromycin on the clinical and antimicrobial effectiveness of tobramycin in the treatment of cystic fibrosis
28. Dectin-1-Independent Macrophage Phagocytosis of Mycobacterium abscessus
29. Divergent host innate immune response to the smooth-to-rough M. abscessus adaptation to chronic infection
30. 29 - Nontuberculous Mycobacterial Disease
31. Diagnosis of Adult Patients with Cystic Fibrosis
32. Nontuberculous Mycobacterial Infections in Cystic Fibrosis
33. Nontuberculosis Mycobacterial Disease
34. Contributors
35. Prevention of transmission of Mycobacterium abscessus among patients with cystic fibrosis
36. Headspace Solid-Phase Micro-Extraction Method Optimization and Evaluation for the Volatile Compound Extraction of Bronchoalveolar Lung Lavage Fluid Samples.
37. Nontuberculous Mycobacterial Infections in Cystic Fibrosis
38. Molecular Epidemiologic Investigation of Mycobacterium intracellulare subspecies chimaera Lung Infections at an Adult Cystic Fibrosis Program
39. Deficient Complement Opsonization Impairs Mycobacterium avium Killing by Neutrophils in Cystic Fibrosis
40. Correlation between Antimicrobial Resistance Mutations and in Vitro Susceptibility in Mycobacterium Abscessus Isolates from People with Cystic Fibrosis
41. Culture independent markers of nontuberculous mycobacterial (NTM) lung infection and disease in the cystic fibrosis airway
42. Specificity of Immunoglobulin Response to Nontuberculous Mycobacteria Infection in People with Cystic Fibrosis
43. Effects of azithromycin in Pseudomonas aeruginosa burn wound infection
44. Selective Metabolism of Hypothiocyanous Acid by Mammalian Thioredoxin Reductase Promotes Lung Innate Immunity and Antioxidant Defense
45. Neutrophils Regulate Tissue Neutrophilia in Inflammation via the Oxidant-modified Lipid Lysophosphatidylserine
46. Nontuberculous mycobacteria in cystic fibrosis: Updates and the path forward
47. Phage Therapy of Mycobacterium Infections: Compassionate Use of Phages in 20 Patients With Drug-Resistant Mycobacterial Disease
48. Breath biomarkers associated with nontuberculosis mycobacteria disease status in persons with cystic fibrosis: a pilot study
49. Blood mRNA biomarkers distinguish variable systemic and sputum inflammation at treatment initiation of inhaled antibiotics in cystic fibrosis: A prospective non-randomized trial
50. Investigating Nontuberculous Mycobacteria Transmission at the Colorado Adult Cystic Fibrosis Program
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.